TL;DR:
14% of consumers actively improving their diet have started a GLP-1 appetite suppressant, according to Mintel BFY Eating Trends 2025. Combined with 53% focusing on protein, 51% watching portions, and 40% prioritizing fiber, the data points to a fundamental shift in what consumers need from food products. F&B manufacturers face a new design brief: protein-dense, fiber-rich, portion-controlled products that deliver maximum nutrition in smaller servings. The manufacturers who capture this market will be those whose product development infrastructure enables simultaneous multi-SKU reformulation at speed.
GLP-1 receptor agonists — the class of medications that includes semaglutide and tirzepatide — are no longer a pharmaceutical niche. They are a consumer behavior shift with direct implications for food manufacturing. Mintel’s 2025 Better For You Eating Trends data shows that 14% of consumers who are actively improving their diet have started a GLP-1 receptor agonists and appetite regulation appetite suppressant. That is not a marginal statistic — it represents millions of consumers whose relationship with food is fundamentally changing.
GLP-1 users eat less volume. They report reduced appetite and earlier satiety. But they do not stop caring about what they eat — they care more. Every calorie has to earn its place. Every serving needs to deliver maximum nutritional value. The Mintel data captures this convergence precisely: 53% of health-active consumers are focusing on protein from food sources, 51% are watching portions and servings, and 40% are prioritizing fiber from fruits, vegetables, and whole grains. These are not separate consumer segments making separate demands. They are overlapping behaviors that describe a single, large, and growing consumer profile: someone who needs more nutrition in less food.
For F&B manufacturers, each of these behavioral shifts creates a product development requirement. Consider a snack bar brand whose core consumer base starts on GLP-1 medications. That brand now needs to simultaneously develop smaller portion sizes (requiring new packaging specifications and new cost-per-unit calculations), higher protein formulations (requiring new recipes and potentially new ingredient suppliers), fiber fortification (requiring new functional ingredients with different regulatory and allergen profiles), and updated nutritional labeling that reflects all of these changes — across their entire portfolio. This is not a single product reformulation. It is a portfolio-wide development program running in parallel.
The GLP-1 effect is not creating a single new product category — it is reshaping demand signals across existing categories simultaneously. The Mintel data maps the landscape clearly.
High-protein, nutrient-dense formats. With 53% of health-active consumers focusing on protein and 33% interested in products that blend animal and plant protein sources, the demand is not just for more protein but for more diverse protein delivery. Hybrid formulations — combining whey with pea protein, collagen with legume blends — require multi-source ingredient management and nutritional profiling that accounts for amino acid completeness, not just total protein grams.
Fiber-fortified products across categories. 40% are prioritizing fiber, but fiber fortification is technically demanding. Adding inulin or psyllium to a snack bar changes texture, moisture content, shelf life, and potentially allergen classification. 40% of consumers also want additional nutrients from whole-food ingredients rather than synthetic additives — meaning manufacturers cannot simply add a fiber supplement and call it done. The fiber source itself matters.
Portion-controlled and nutrient-dense servings. 51% are watching portions, but smaller portions do not mean simpler products. A 150-calorie protein bar that delivers 20g of protein and 5g of fiber in a portion designed for a GLP-1 user is a more complex formulation challenge than a standard 250-calorie bar. Every gram of the formulation has to work harder nutritionally, while still delivering on taste and texture.
Trend-responsive innovation. Market signals are moving fast. Cottage cheese sales surged 166% on GoPuff in 2024, driven by social media virality and protein positioning. 40% of consumers want prepared foods with more servings of vegetables. When a category goes viral or a nutritional trend accelerates, the manufacturers who capture the market are those whose product development infrastructure can move from insight to shelf-ready product in weeks, not quarters.
The GLP-1 trend does not create a single reformulation project. It creates dozens of simultaneous reformulation projects across a manufacturer’s portfolio — each with different protein targets, fiber fortification strategies, portion specifications, and regulatory requirements per market. The bottleneck is not ideas. R&D teams know what products GLP-1 consumers need. The bottleneck is execution: the ability to run parallel reformulation workstreams without each one creating a compliance and coordination bottleneck for the others.
When a manufacturer needs to reformulate 20–30 SKUs simultaneously for protein fortification, portion control, and updated labeling, three capabilities determine whether they capture the market or watch competitors do it:
Formulation iteration speed. Each SKU requires multiple recipe versions — testing different protein sources, fiber types, and portion configurations. Without a system that manages formulation versioning centrally, each SKU becomes an isolated project with its own timelines, its own ingredient conflicts, and its own duplication of effort.
Regulatory validation per market. A protein content claim that meets FDA requirements for protein content claims may not meet EU or UK thresholds. Fiber claims have similar cross-market variation. When reformulating dozens of SKUs across multiple markets, regulatory validation cannot be sequential — it must happen in parallel, within the formulation workflow, flagging issues before production rather than after.
Packaging and labeling coordination. New portion sizes mean new packaging. New formulations mean new nutrition facts panels and potentially new front-of-pack claims. When formulation, packaging, and labeling are managed in disconnected systems, a single change cascades into manual updates across multiple teams — and that is where errors enter.
The manufacturers already operating at this speed — companies like Barilla and Ocean Spray, managing complex product portfolios across global markets — are the ones whose PLM software for food and beverage manufacturers connects formulation, regulatory compliance, and labeling in a single workflow. As CIMdata research on PLM agility confirms, the ability to maintain product integrity while accelerating time to market is the defining competitive advantage in consumer goods — and the GLP-1 trend is making that advantage decisive.
The consumer mandate is clear: why naturally low reformulation is the new consumer mandate is now compounded by the GLP-1 effect, which adds protein density, fiber fortification, and portion control to an already complex reformulation agenda. The manufacturers who treat what is product lifecycle management as their core innovation infrastructure — not just a project management tool — are the ones who will convert this demand into shelf-ready products while the market is still emerging.
Key TakeawayGLP-1 medications are reshaping F&B demand: 14% of health-active consumers are already using them, driving demand for protein-dense, fiber-rich, portion-controlled products. The manufacturers who capture this market will be those whose PLM enables simultaneous multi-SKU reformulation with integrated regulatory compliance. |
The GLP-1 trend is rewriting F&B product development. Is your infrastructure ready?
See how PLM software for food and beverage manufacturers enables simultaneous multi-SKU reformulation with integrated regulatory compliance — so your team captures emerging demand while the market is still forming.
With more than 30 years of industry expertise, Trace One partners with over 9,000 brands across food and beverage, cosmetics, and chemicals to accelerate product development and turn regulatory complexity into a competitive advantage. Our AI-powered PLM platform, with regulatory intelligence spanning 170+ countries, supports the entire product manufacturing lifecycle — helping brands bring market-leading products to shelf faster and thrive in new markets. Learn more at traceone.com.